Set new standards in infection control, environmental effectiveness logistical cost savings, and compliance.
Vials or other collectors that have less than 3% of the original contents by weight, after removing as much of the chemotherapy medicine as feasible and by normal means. Trace chemotherapy waste typically exhibits reactivity, toxicity, ignitability and corrosivity.
Waste includes: Any empty chemotherapy drug containers, intravenous bags/bottles and IV tubing that do not hold a P-listed chemotherapy medicine.
All empty bags, drug vials/needles, containers gloves and tubing with chemotherapy medicine remaining from use during chemotherapy infusions.
Any PPE, masks, gowns and other materials used during chemotherapy infusions that are visibly contaminated.
The term “bulk” chemotherapy is defined as chemo waste that exceeds 3% by volume and is considered a RCRA hazardous waste. Full bags or bottles and P-listed chemotherapy drugs fall under RCRA hazardous waste regulations and are handled as RCRA hazardous waste by Medical Systems.